《Nature》专题:被忽视的疾病

【字体: 时间:2007年09月27日 来源:生物通

编辑推荐:

  热带疾病给10多亿人类带来了无尽的痛苦,但是至今为止有效的治疗方法并不多,而且虽然进行了许多科学研究,但是许多具有治疗潜力的科学创新并不能从实验室里走出来。 《Nature》杂志最新副刊以“Neglected diseases”为题,提示大家关注这一领域,也审视了促进有效医药发展,以及将这些方法传递给最需要的人的处理办法。

  

生物通报道:热带疾病给10多亿人类带来了无尽的痛苦,但是至今为止有效的治疗方法并不多,而且虽然进行了许多科学研究,但是许多具有治疗潜力的科学创新并不能从实验室里走出来。

《Nature》杂志最新副刊以“Neglected diseases”为题,提示大家关注这一领域,也审视了促进有效医药发展,以及将这些方法传递给最需要的人的处理办法。

Neglected Diseases p157

David O'Connell

doi:10.1038/449157a


Lost in translation p158

The culture of academia needs to change if scientists are to bridge the gap between research and the development of drugs and vaccines for neglected diseases in the developing world, says Declan Butler.

Declan Butler

doi:10.1038/449158a


A tough transition p160

What is holding back biotechnology in the developing world? Peter A. Singer and his colleagues listen to those on the ground.

Peter A. Singer, Kathryn Berndtson, C. Shawn Tracy, Emma R. M. Cohen, Hassan Masum, James V. Lavery & Abdallah S. Daar

doi:10.1038/449160a


The path to new medicines p164

Governments must help accelerate the development of drugs needed to treat infectious diseases in the developing world, say Bénédicte Callan and Iain Gillespie.

Bénédicte Callan & Iain Gillespie

doi:10.1038/449164a


Mission possible p166

One billion people worldwide suffer from tropical diseases. Andrew L. Hopkins, Michael J. Witty and Solomon Nwaka explain how drug-discovery networks might be scaled up to address the lack of treatments cost-effectively.

Andrew L. Hopkins, Michael J. Witty & Solomon Nwaka

doi:10.1038/449166a


A prescription for drug delivery p170

Improvements in basic infrastructure are the key to saving millions of lives each year, say Julian Lob-Levyt and his colleagues.

Rebecca Affolder, Ivone Rizzo, Craig Burgess, Abdallah Bchir & Julian Lob-Levyt

doi:10.1038/449170a


Patent sense p174

Protecting intellectual property saves lives in the developing world, argues Paul Herrling.

Paul Herrling

doi:10.1038/449174a


At what price? p176

Differential pricing could make global medicines affordable in developing countries. But drugs for diseases that have no market in the developed world will require additional subsidies, says Patricia M. Danzon.

Patricia M. Danzon

doi:10.1038/449176a


The road to recovery p180

Brazil urgently needs to improve infrastructure for generating pharmaceuticals to alleviate the plight of its poor and marginalized populations, say Carlos M. Morel et al.

Carlos M. Morel, José R. Carvalheiro, Carmen N. P. Romero, Eduardo A. Costa & Paulo M. Buss

doi:10.1038/449180a

 

 

相关新闻
生物通微信公众号
微信
新浪微博
  • 搜索
  • 国际
  • 国内
  • 人物
  • 产业
  • 热点
  • 科普
  • 急聘职位
  • 高薪职位

知名企业招聘

热点排行

    今日动态 | 人才市场 | 新技术专栏 | 中国科学人 | 云展台 | BioHot | 云讲堂直播 | 会展中心 | 特价专栏 | 技术快讯 | 免费试用

    版权所有 生物通

    Copyright© eBiotrade.com, All Rights Reserved

    联系信箱:

    粤ICP备09063491号